The Journal of Organic Chemistry
Article
132.2, 131.6, 130.6, 130.2, 127.1, 116.4, 114.7, 55.5, 52.40; 19F NMR
(235 MHz, CDCl3) δ = −141.31 (10B-F, 0.2F), −141.37 (11B-F, 0.8F);
LRMS (EI) (positive mode) m/z 541.2 [M + Na]+, 557.2 [M + K]+.
Anal. Calcd for C29H25BF2O6·1/3CH2Cl2: C, 64.45; H, 4.73. Found: C,
64.09; H, 4.38.
and was filtered from ethyl acetate (319 mg, 44%): mp = 234−235 °C;
1H NMR (250 MHz, CDCl3) δ = 8.50 (d, 3J = 15.4 Hz, 2H), 8.26 (d,
3J = 8.3 Hz, 2H), 8.20 (d, 3J = 8.3 Hz, 2H), 7.47 (m, 10H), 6.72 (d, 3J
3
= 8.3 Hz, 2H), 6.53 (d, J = 15.4 Hz, 2H), 3.97 (s, 6H); 13C NMR
(62.5 MHz, CDCl3) δ = 182.5, 157.3, 137.6, 135.8, 132.6, 132.4, 128.6,
127.6, 127.4, 125.9, 125.5, 125.1, 123.2, 122.5, 122.4, 116.0, 103.8,
55.6; LRMS (EI) (positive mode) m/z 513.1 [M + H]+, (negative
mode) 511.2 [M − H]−. Anal. Calcd for C35H28O4: C, 82.01; H, 5.51.
Found: C, 81.83; H, 5.67. This compound (150 mg, 0.29 mmol) was
reacted with boron trifluoride etherate to afford the boron complex 2-
Ph as a red solid (164 mg, quantitative): mp = 299−301 °C; 1H NMR
(250 MHz, CDCl3) δ = 8.88 (d, 3J = 15.2 Hz, 2H), 8.25 (m, 4H), 7.56
(1E,4Z,6E)-5-(Difluoroboryloxy)-1,7-bis(4-methoxyphenyl)-
hepta-1,4,6-trien-3-one (1-H). The free compound38 (149 mg, 0.44
mmol) was reacted with boron trifluoride etherate to afford the crude
complex 1-H that was purified by column chromatography on silica
using Et2O/cyclohexane (1/1) as eluent. Red solid (170 mg, 74%):
1
3
mp = 247−249 °C; H NMR (250 MHz, CDCl3) δ = 7.98 (d, J =
15.4 Hz, 2H), 7.55 (d, 3J = 8.8 Hz, 4H), 6.92 (d, 3J = 8.8 Hz, 4H), 6.56
(d, J = 15.4 Hz, 2H), 5.98 (s, 1H), 3.84 (s, 6H); 13C NMR (62.5
3
3
3
(m, 9H), 7.37 (m, 2H), 6.76 (d, J = 8.4 Hz, 2H), 6.56 (d, J = 15.2
Hz, 2H), 4.00 (s, 6H); 13C NMR (62.5 MHz, CDCl3) δ = 177.4,
159.1, 143.6, 133.1, 132.9, 132.1, 129.1, 128.6, 128.2, 127.9, 129.0,
125.5, 124.1, 123.1, 122.7, 118.8, 104.0, 55.8; 19F NMR (235 MHz,
CDCl3) δ = −141.17 (10B-F, 0.2), −141.11 (11B-F, 0.8); LRMS (EI)
(positive mode) m/z 583.2 [M + Na]+, 599.2 [M + K]+; HR-MS (ESI
+) [M + Na]+ calcd for C35H27O4BF2Na+ 583.1869, found 583.1868.
(1E,4Z,6E)-5-(Difluoroboryloxy)-1,7-bis(6-methoxynaphtha-
len-2-yl)-4-phenylhepta-1,4,6-trien-3-one (3). The free ligand
was obtained as a yellow solid from meso-(phenyl)-acacH (224 mg,
1.27 mmol) and 6-methoxy-2-naphthaldehyde (474 mg, 2.54 mmol)
and was filtered from ethyl acetate (450 mg, 69%): mp = 278−279 °C;
1H NMR (250 MHz, CDCl3) δ = 7.83 (d, 3J = 15.6 Hz, 2H), 7.74 (s,
MHz, CDCl3) δ = 179.5, 162.8, 146.9, 131.2, 127.0, 119.1, 114.8,
101.6, 55.2; 19F NMR (235 MHz, CDCl3) δ = 140.96 (10B-F, 0.2F),
−141.08 (11B-F, 0.8F); LRMS (EI) (positive mode) m/z 407.1 [M +
Na]+, 423 [M + K]+; HRMS (ESI+) [M + Na]+ calcd for
C21H19O4BF2Na+ 407.1241, found 407.1238.
(1E,4Z,6E)-5-(Difluoroboryloxy)-1,7-bis(4-methoxyphenyl)-
4-phenylhepta-1,4,6-trien-3-one (1-Ph). The free ligand was
obtained as a yellow solid from meso-(phenyl)-acacH (350 mg, 1.99
mmol) and p-methoxybenzaldehyde (542 mg, 3.98 mmol) and was
purified by column chromatography on silica using cyclohexane/
1
AcOEt (1/9 v:v) as eluent (205 mg, 25%): mp = 171−172 °C; H
3
NMR (250 MHz, CDCl3) δ = 7.64 (d, J = 15.6 Hz, 2H), 7.43 (m,
3
3
3H), 7.27 (m, 6H), 6.80 (d, J = 8.8 Hz, 4H), 6.35 (d, J = 15.6 Hz,
1H), 3.78 (s, 6H); 13C NMR (62.5 MHz, CDCl3) δ = 182.5, 161.2,
140.6, 135.6, 132.3, 129.8, 128.5, 128.1, 127.6, 120.1, 115.9, 114.2,
55.3; LRMS (EI) (positive mode) m/z 413.2 [M + H]+, 435.2 [M +
Na]+, (negative mode): 411.3 [M − H]−. Anal. Calcd for C27H24O4:
C, 78.62; H, 5.86. Found: C, 78.27; H, 5.91.This compound (200 mg,
0.48 mmol) was reacted with boron trifluoride etherate to afford the
boron complex 1-Ph as a red solid (223 mg, quantitative): mp = 227−
229 °C; 1H NMR (250 MHz, CDCl3) δ = 8.02 (d, 3J = 15.3 Hz, 2H),
7.50 (m, 3H), 7.35 (d, 3J = 9.0 Hz, 4H), 7.28 (m, 1H), 6.84 (d, 3J = 9.0
3
3
2H), 7.69 (d, J = 8.9 Hz, 2H), 7.58 (d, J = 8.6 Hz, 2H), 7.48 (m,
3H), 7.34 (m, 4H), 7.11 (dd, 3J = 8.9 Hz, 4J = 2.4 Hz, 2H), 7.05 (d, 4J
3
= 2.4 Hz, 2H), 6.56 (d, J = 15.6 Hz, 2H), 3.90 (s, 6H); 13C NMR
(62.5 MHz, CDCl3) δ = 182.5, 158.8, 141.3, 135.5, 132.4, 130.7, 130.1,
129.9, 128.7, 128.6, 127.7, 127.3, 124.3, 121.4, 119.3, 116.3, 106.0,
55.4; LRMS (EI) (positive mode) m/z 513.1 [M + H]+, (negative
mode) 511.2 [M − H]−. Anal. Calcd for C35H28O4: C, 82.01; H, 5.51.
Found: C, 82.23; H, 5.60. This compound (118 mg, 0.23 mmol) was
reacted with boron trifluoride etherate to afford the boron complex 3
1
as a red solid (129 mg, quantitative): mp = 239−241 °C; H NMR
3
Hz, 4H), 6.35 (d, J = 15.3 Hz, 2H), 3.81 (s, 6H); 13C NMR (62.5
3
4
(250 MHz, CDCl3) δ = 8.20 (d, J = 15.4 Hz, 2H), 7.83 (d, J = 1.1
Hz, 2H), 7.72 (d, 3J = 9.0 Hz, 2H), 7.60 (d, 3J = 8.7 Hz, 2H), 7.55 (m,
3H), 7.35 (m, 4H), 7.14 (dd, 3J = 8.9 Hz, 4J = 2.4 Hz, 2H), 7.04 (d, 4J
MHz, CDCl3) δ 177.7, 162.7, 147.2, 132.8, 132.0, 131.3, 129.1, 128.7,
127.3, 117.0, 114.6, 55.5; 19F NMR (235 MHz, CDCl3) δ = −141.25
(10B-F, 0.2F), −141.31 (11B-F, 0.8F); LRMS (EI) (positive mode) m/z
483.1 [M + Na]+, 499.0 [M + K]+; HRMS (ESI+) [M + Na]+ calcd for
C27H23O4BF2Na+ 483.1555, found 483.1555.
3
= 2.3 Hz, 2H), 6.57 (d, J = 15.4 Hz, 2H), 3.90 (s, 6H); 13C NMR
(62.5 MHz, CDCl3) δ = 177.9, 159.7, 147.9, 136.5, 132.7, 132.3, 132.1,
130.7, 129.9, 129.2, 128.8, 128.6, 127.6, 124.3, 119.7, 118.4, 116.0,
106.2, 55.4; 19F NMR (235 MHz, CDCl3) δ = 140.95 (10B-F, 0.2),
141.01 (11B-F, 0.8); LRMS (EI) (positive mode) m/z 583.2 [M +
Na]+, 599.2 [M + K]+. Anal. Calcd for C35H28BF2O4·1/5CH2Cl2: C,
73.22; H, 4.78. Found: C, 73.59; H, 4.77.
(1E,4Z,6E)-5-(Difluoroboryloxy)-1,7-bis(4-methoxynaphtha-
len-1-yl)hepta-1,4,6-trien-3-one (2-H). The free ligand was
obtained as an orange solid from acacH (305 mg, 3.05 mmol) and
4-methoxy-1-naphthaldehyde (1.14 g, 6.11 mmol) and was filtered
from ethyl acetate (813 mg, 61%): mp = 233−234 °C; 1H NMR (250
MHz, CDCl3) δ = 8.48 (d, 3J = 15.5 Hz, 2H), 8.32 (dd, 3J = 8.3 Hz, 4J
(1E,4Z,6E)-5-(Difluoroboryloxy)-1,7-bis(9-methyl-9H-carba-
zol-3-yl)-4-phenylhepta-1,4,6-trien-3-one (4). The free ligand
was obtained as an orange-red solid from meso-(phenyl)-acacH (200
mg, 1.13 mmol) and N-methylcarbazole-3-carboxaldehyde (475 mg,
2.27 mmol) and was filtered from ethyl acetate (266 mg, 42%): mp =
3
3
= 1.0 Hz, 2H), 8.24 (d, J = 8.3 Hz, 2H), 7.79 (d, J = 8.2 Hz, 2H),
3
3
7.57 (m, 4H), 6.85 (d, J = 8.0 Hz, 2H), 6.66 (d, J = 15.5 Hz, 2H),
5.98 (s, 1H), 4.04 (s, 6H); 13C NMR (62.5 MHz, CDCl3): δ = 183.4,
157.4, 137.2, 132.6, 127.4, 125.8, 125.6, 125.6, 124.8, 124.2, 123.2,
122.6, 103.9, 101.7, 55.7; LRMS (EI): (positive mode) m/z 437.1 [M
+ H]+, 459.1 [M + Na]+, 478.1 [M + K]+. Anal. Calcd for C29H24O4:
C, 79.80; H, 5.54. Found: C, 79.79; H, 5.53. This compound (110 mg,
0.25 mmol) was reacted with boron trifluoride etherate to afford the
crude boron complex 2-H as a black solid that was purified by column
chromatography on silica using cyclohexane/DCM (2/3) as eluent (63
mg, 52%): mp = 309−311 °C; 1H NMR (250 MHz, CDCl3) δ = 8.88
1
4
256−258 °C; H NMR (250 MHz, CDCl3) δ = 8.07 (d, J = 1.3 Hz,
3
3
2H), 8.03 (d, J = 8.0 Hz, 2H), 7.93 (d, J = 15.5 Hz, 2H), 7.44 (m,
12H), 7.27 (m, 3H), 6.55 (d, J = 15.7 Hz, 2H), 3.81 (s, 6H); 13C
3
NMR (62.5 MHz, CDCl3) δ = 182.6, 142.2, 142.0, 141.4, 136.0, 132.6,
128.5, 127.5, 126.6, 126.2, 125.9, 123.2, 122.7, 121.3, 120.5, 119.6,
119.5, 115.8, 108.8, 108.7, 29.2; LRMS (EI) (positive mode) m/z
559.2 [M + H]+, (negative mode) 557.3 [M − H]−. Anal. Calcd for
C39H30N2O2: C, 83.85; H, 5.41; N, 5.01. Found: C, 84.07; H, 5.38; N,
4.86. This compound (111 mg, 0.20 mmol) was reacted with boron
trifluoride etherate to afford the boron complex 4 as a red solid (121
mg, quantitative): mp = 309−311 °C; 1H NMR (250 MHz, CDCl3) δ
3
3
(d, J = 15.3 Hz, 2H), 8.32 (m, 4H), 7.94 (d, J = 8.3 Hz, 2H), 7.60
(m, 4H), 6.90 (d, 3J = 8.5 Hz, 2H), 6.79 (d, 3J = 15.5 Hz, 2H), 6.12 (s,
1H), 4.08 (s, 6H); 13C NMR (62.5 MHz, CDCl3): Because of the
poor solubility of 2-H, a satisfactory 13C NMR spectrum could not be
obtained; 19F NMR (235 MHz, CDCl3) δ = −140.84 (10B-F, 0.2),
−140.90 (11B-F, 0.8); LRMS (EI) (positive mode) m/z 485.1 [M +
H]+, 507.1 [M + Na]+, 523.1 [M + K]+, 502.2 [M + NH4]+. Anal.
Calcd for C29H23BF2O4: C, 71.92; H, 4.79. Found: C, 72.12; H, 4.76.
(1E,4Z,6E)-5-(Difluoroboryloxy)-1,7-bis(4-methoxynaphtha-
len-1-yl)-4-phenylhepta-1,4,6-trien-3-one (2-Ph). The free ligand
was obtained as an orange solid from meso-(phenyl)-acacH (249 mg,
1.41 mmol) and 4-methoxy-1-naphthaldehyde (527 mg, 2.83 mmol)
3
4
3
= 8.29 (d, J = 15.4 Hz, 2H), 8.13 (d, J = 1.1 Hz, 2H), 8.05 (d, J =
9.0 Hz, 2H), 7.60 (m, 3H), 7.51 (m, 4H), 7.41 (m, 4H), 7.30 (d, 3J =
8.3 Hz, 4H), 6.54 (d, 3J = 15.4 Hz, 2H), 3.90 (s, 6H); 13C NMR (62.5
MHz, CDCl3) δ = 177.1, 148.7, 143.1, 141.3, 133.3, 132.3, 129.1,
128.6, 127.1, 126.6, 125.8, 123.4, 122.9, 122.6, 120.6, 120.2, 116.2,
113.5, 109.1, 109.0, 29.3; 19F NMR (235 MHz, CDCl3) δ = −140.95
(10B-F, 0.2), −141.01 (11B-F, 0.8); LRMS (EI) (positive mode) m/z
629.2 [M
+ +
Na]+, 645.2 [M K]+. Anal. Calcd for
H
dx.doi.org/10.1021/jo400389h | J. Org. Chem. XXXX, XXX, XXX−XXX